Prestige Consumer Healthcare Inc

PBH: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
fjLOCK|pyR$LOCK|ZGC^H>!

Prestige Earnings: Continued Clear Eyes Variability Reduces Full-Year Outlook

Prestige Consumer Healthcare delivered second-quarter revenue growth of 23% this quarter (negative 2% organic), and adjusted EPS of 6%, both ahead of FactSet consensus. Management lowered full-year revenue and EPS guidance to midpoint figures of $1.29 billion and $4.52, respectively.

Sponsor Center